ATRA
Atara Biotherapeutics Inc
9.20$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -12.3% | -0.1% | -29.0% | +21.7% | -23.6% | -43.1% | -40.5% | -18.3% | -32.9% | -1.2% | +5.1% | |
| – | -14.2% | +4.5% | -41.4% | +47.2% | -29.4% | -58.1% | -8.9% | -25.6% | -33.7% | -0.3% | +11.1% | |
| – | -60.1% | +35.8% | -10.8% | +48.3% | -46.1% | -44.7% | +22.1% | -66.0% | +47.7% | -1.4% | -61.5% | |
| – | -49.5% | -10.6% | -23.7% | +90.4% | -36.8% | -67.4% | +61.3% | -38.6% | -38.1% | -1.4% | +18.1% | |
| – | +20,825.2% | +5.1% | -93.2% | -44.9% | +11.0% | +498.9% | -100.0% | – | -34.5% | -100.0% | – | |
| – | +47.3% | +65.7% | +16.6% | -25.4% | -23.8% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.5% | -0.4% | -13.4% | +2.2% | -11.5% | -43.3% | -38.6% | -7.1% | -12.1% | -2.4% | +1.2% | |
| – | +79.8% | +27.0% | -17.9% | +5.2% | -13.7% | -64.4% | -69.6% | +24.0% | -17.4% | -62.2% | +21.3% | |
| – | -8.4% | +15.2% | -0.2% | +4.7% | -5.1% | 0.0% | -83.9% | +418.4% | -7.3% | -90.6% | +8.2% | |
| – | -43.4% | -22.5% | +84.1% | -59.1% | +103.5% | -68.3% | +27.3% | -82.0% | -60.1% | +401.6% | +29.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.6% | +30.0% | +9.2% | +21.5% | +43.2% | +1.5% | +13.4% | +10.2% | -6.2% | +10.7% | +6.8% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.